In subjects with metastatic melanoma, the gut microbiome diversity was remarkably enhanced in responder cases to PD‐1 blockade treatment, and specific bacterial species were relatively more enriched, like Faecalibacterium, Ruminococcaceae, and Clostridiales.63, 66. The gene discussed is PDCD1; the disease is metastatic melanoma.